Sarepta Therapeutics (SRPT) Inventory (2016 - 2026)

Sarepta Therapeutics' Inventory history runs 11 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• On a quarterly basis, Inventory rose 6.34% year-over-year to $1.0 billion in Q1 2026; TTM through Mar 2026 was $1.0 billion, a 6.34% increase from a year earlier, with the FY2025 full-year figure at $914.7 million, up 21.97% from the prior year.
• Inventory grew to $1.0 billion in Q1 2026 per SRPT's latest filing, from $914.7 million in the prior quarter.
• Across five years, Inventory topped out at $1.1 billion in Q3 2025 and bottomed at $199.0 million in Q1 2022.
• The 5-year median for Inventory is $373.5 million (2024), against an average of $525.4 million.
• Across the five-year window, Inventory slipped 23.32% in 2022 and jumped 152.04% in 2025, its largest moves.
• Year by year, Inventory stood at $204.0 million in 2022, then surged by 58.29% to $322.9 million in 2023, then jumped by 132.29% to $750.0 million in 2024, then increased by 21.97% to $914.7 million in 2025, then climbed by 9.44% to $1.0 billion in 2026.
• Per Business Quant, the three latest SRPT Inventory figures stand at $1.0 billion (Q1 2026), $914.7 million (Q4 2025), and $1.1 billion (Q3 2025).